View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The four organisations have written a template letter which anyone can send to any company they see using brachycephalic breeds, such as the Persian, or Scottish Folds, in its marketing materials.
The letter urges companies that use images of cats to work collaboratively with veterinary professionals and pledge to avoid using such breeds in the future.
Dr Nathalie Dowgray, Head of ISFM, said: “Seeing a cute cat in an advertisement can often be a trigger for people to seek out acquiring a cat of that breed without understanding the welfare concerns associated with some pedigree breeds.
"A rise in demand can lead to an increase in breeding practices that result in severe conformational issues and poorer welfare in these breeds.
"We encourage people to download this letter to use when they see breeds of concern being used in advertising, as health is always more important than looks.”
https://icatcare.org/app/uploads/2023/09/ISFM_FECAVA_FVE_UEVPAdvert_Letter.pdf.
EQVALAN® manufacturer Merial Animal Health is extending its free egg worm count promotion, allowing practices to re-run the offer this autumn.
During September and October Merial is giving away 20 free faecal egg count tests with each order of 20 tubes of EQVALAN® DUO (ivermectin + praziquantel). In addition, for every 20 tubes ordered, stockists will get a further 4 tubes of EQVALAN® DUO free.
EQVALAN's product manager Claire Edmunds said: "During the spring campaign, over 1000 horse owners took part in the worm egg count promotion, many of whom we believe had never used testing kits before.
"The tests highlight which horses need treatment and which do not, allowing practices to advise specifically on the necessary treatment*.
For those practices with their own testing facilities, Merial is also offering promotional support to help encourage increased uptake and client buy-in. "The autumn campaign will provide participating practices with another opportunity to add value whilst encouraging loyalty from clients.
Claire added: "Promoting a targeted approach to responsible worming means that only those horses which need treatment are wormed with an appropriate wormer selected for the worms identified from the test."
For further information please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.
They include the successful completion of its governance review, the launch of the Graduate Outcomes consultation (the biggest in 20 years) and the Edward Jenner Leadership Programme (a massive open online course to develop leadership skills at all levels of the profession).
The College also highlights the continuation of its Mind Matters Initiative and how the initiative's aim - to encourage a compassionate and empathetic profession - is becoming a central part of the College's core strategy.
The report also covers the work done by the College to explore an outcomes-based approach to continuing professional development (CPD), review Schedule 3 and the Veterinary Surgeons Act, plan for the UK’s exit from the European Union and promote (jointly with the BVA) the benefit of registering with a vet to the public via a social media campaign.
The report includes the College’s independently-audited finances with details of income and expenditure. Whilst the College is not a charity, the accounts have been prepared in accordance with the Charities Statement of Recommended Practice – a framework for charity accounting and reporting, which allows easier comparison with the finances of similar bodies.
The report will be presented for adoption by members of the College at this year’s RCVS Day on Friday 12 July 2019 at the Royal Institute of British Architects.
The report can be downloaded from the RCVS publications webpage, or contact publications@rcvs.org.uk to request a hard copy.
Boehringer Ingelheim Vetmedica has added a cardiology CPD section to its Vetmedin website. The section also includes a number of owner education resources to be used in practice.
The site, which is billed as a one-stop-shop on canine heart disease, includes an interactive radiology viewer, the Vetmedin atlas of cardiac radiology, radiology interpretation and diagnosis, an interactive MVD seminar and online downloadable Vetmedin dosage calculator to assist veterinary surgeons in prescribing the optimum dose.
Owner education materials include an animation explaining how to monitor a dog's resting respiratory rate, a video about heart failure and downloadable charts to help owners monitor their dog's condition.
For further information, visit www.vetmedin.co.uk, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
Zea Sciences has announced that its natural rodenticide has been certified under the European Biocide Directive Program, known as Annex1/1A BPD 98/8EEC.
The rodenticide is made from powdered corn cob (PCC) which, according to Zea Sciences, causes rats and mice to die of hypovolemic shock within 4-7 days of starting to feed on it.
The company says PCC poses no health risk to human or non target animal species, such as cats, dogs and birds. It is also the first of its type and class to be officially acknowledged as using naturally biodegradable and environmentally friendly material.
PCC is available from a number of retail and trade outlets, under various different brand names. However, the company said that if there was sufficient interest by vets in stocking the pet-friendly product, it would look at making it available through veterinary wholesalers.
Martin Holland, Managing Director of Zea Sciences said: ''I hope the profession will help spread the word about PCC-based rodent control - it might mean you have to reach for the vitamin K a little less often."
Forte developed the new solution alongside Professor Gayle Hallowell, Professor of Veterinary Internal Medicine and Critical Care at the School of Veterinary Medicine and Science, University of Nottingham.
The company says Hydrafast delivers ideal levels of sodium and glucose. It also contains glycine, an amino acid, acetate, propionate and citrate.
Professor Hallowell said: “This new ORS formula for calves is both practical and research-based, and should address what we know calves need when they have diarrhoea. It provides nutrition as well as an optimal electrolyte balance.”
Hydrafast comes in sachets of 133g. Each box of Hydrafast contains 24 sachets.
Hydrafast is available now from all major veterinary wholesalers, or direct from Forte Healthcare Ltd.
For more information contact your Forte Territory Manager, email enquiries@fortehealthcare.com or visit: www.fortehealthcare.com/product/hydrafast/
Grahame Gardner has introduced the M559, a classically styled tunic, stocked for the first time in bottle green.
The company says that although it has sold numerous ladies tunics in bottle green, this is the first time it has stocked a male tunic in the characteristic veterinary colour.
The M559 incorporates side fastening with the option of contrasting epaulettes, alongside practical pockets and side slits.
Simon Ward, Sales Director said: "We are delighted to introduce this new garment to the veterinary market. We are continually reviewing our range in response to customer comments, and felt it was time we stocked a bottle green option, specifically for male members of the veterinary team."
Stocked in sizes from 34" to 50" (chest), the M559 is just one of several new styles introduced in Grahame Gardner's latest brochure. The company is also launching a new men's scrub tunic. The SS3295 has a v style neck, complemented by the v-detail on the sleeves, and contrasting trim available on the neck, sleeve and pocket. Also stocked in bottle green, the company says this tunic is aimed at veterinary professionals who prefer a more relaxed approach to uniforms.
To explore Grahame Gardner's collection please take a look at http://www.grahamegardner.co.uk/, or call 0116 255 6326 to order a copy of their new brochure.
The service, which has been set up by ex-Olympian Lisbet Stuer-Lauridsen (badminton for Denmark, since you ask), is designed to complement the end-of-life care already offered by practices.
Lisbet says that veterinary surgeons already working with Cloud 9 told her they found it difficult to offer the compassionate care pet owners need during a 15 minute consult in a busy practice.
The new service is structured so they have time to spend with the grieving owner to help support them at this sensitive time.
Pet owners make their booking with a dedicated Care Coordinator trained to handle the situation with dignity and respect.
Because the care is then provided at home, the pet doesn’t have to experience the potential anxiety involved in transport to the practice and the owner doesn’t have to worry about trying to hide their grief from other clients in the waiting room, or driving home in a distressed state.
Veterinary surgeons who apply to join the service are given specific training in euthanasia and counselling for all members of the family. The average visit time is expected to be around 1.5 hours to allow the procedure to be carried out with sensitivity and care.
Cloud 9 says the new service offers vets, locum vets and practices a flexible additional revenue stream. Vets can select the days or hours they want to work, to fit around family or other work commitments, and Cloud 9 says it will handle all the paperwork, including payments.
Cloud 9 Vets also offers additional services such as a memory wall and pet cremation.
Lisbet is now inviting vets throughout the country to sign up with Cloud 9’s mobile service. She said: "We want to offer the service in as many locations as possible and welcome the opportunity to work with locums, mobile vets and practices."
For more information, visit: https://cloud9vets.co.uk/join-the-team/
The Health Products Regulatory Authority (HPRA) has also granted a marketing authorisation in exceptional circumstances (Article 25, 26 EU Reg 2019/6) for Bultavo 3 in Ireland.
The company says that so far, more than 40 million doses of Bultavo 3 have been distributed in Europe to help limit the spread of BTV-3.
Boehringer points to a recent field study published by the German reference laboratory Friedrich-Loeffler-Institut (FLI), which showed that vaccination of sheep and cattle with Bultavo 3 induces immunity against the virus1.
According to the study, animals vaccinated with Bultavo 3 consistently showed evidence of a protective antibody response to BTV-3, although animals vaccinated with other BTV-3 vaccines did not1.
Boehringer says it is now compiling the data needed to obtain a full marketing authorisation in accordance with Article 8 of EU Regulation 2019/6.
Reference
MSD has announced that the broad-spectrum clostridial disease vaccine for sheep and cattle, Bravoxin 10, is now available in a new 6 x 100ml farm vaccination pack. The pack contains enough vaccine for 600 sheep or 300 cattle boosters.
Buyers of the new farm pack will also get a free vaccine applicator worth £20. The new Bravoxin 10 applicator benefits from the sterimatic system, which protects and sterilises the vaccination needle with each injection. MSD says it can also be placed down between doses without risk of needle damage, self-injection or needing to remove the vaccine bottle.
Bravoxin 10 protects both cattle and sheep from clostridial diseases like blackleg and black disease, as well as other conditions caused by clostridial bacteria that usually kill the animal once infection has become established. The vaccine protects against disease caused by the 10 main clostridial bacteria; C. perfringens type A, C.perfringens type B, C.perfringens type C, C.perfringens type D, C.novyi type B, C.septicum, C.tetani, C.sordellii, C.haemolyticum and C.chauvoei.
Lynn Jo Ann Davies MRCVS first appeared before the Committee in January 2018 to face a number of charges related to two drink-driving offences, breaching the terms of her undertakings to the College as part of its Health Protocol, and being under the influence of alcohol on three occasions while she was on duty as a veterinary surgeon in December 2016.
Dr Davies admitted all five charges against her and admitted that this meant she was unfit to practise veterinary surgery and that she was guilty of disgraceful conduct in a professional respect. The Committee accepted her admissions and found, with the exception of one allegation, that her conduct was disgraceful in a professional respect.
At its first hearing the Committee having considered both aggravating and mitigating circumstances decided to postpone the hearing for six months on the basis of Dr Davies’ entering into a new set of undertakings, including one not to practise veterinary surgery and to remain abstinent from alcohol during the period of postponement.
At the second hearing, in July 2018, the Disciplinary Committee resumed its sanction inquiry decision. Dr Davies’ Counsel submitted on her behalf that Dr Davies wished to return to practise and the Committee reviewed her witness statements, documentary proof and medical records that she provided to demonstrate she had complied with the her undertakings given at the last hearing.
Stuart Drummond, Chairing the Committee and speaking on its behalf, said: "Having had the opportunity to see and hear from the respondent when she gave evidence and when she answered the questions put to her, the view formed of her current state of health was favourable. All members of the Committee considered that the account she gave of herself in the witness box was confident and they were reassured by her evidence as to how she now sets about managing her levels of stress and how she reacted to stressful incidents.
"Such concerns as the Committee had about her return to practice concerned her ability to receive support from a third party who would act as a mentor…the Committee therefore requires the Respondent to identify, within a period of one month of today’s date, a veterinary surgeon who would agree to act as her mentor. That mentor would have to be a veterinary surgeon acceptable to the College as someone suitable to act in that capacity and that mentor would have to be approved before the Respondent could resume practice.
"A further requirement of the Committee would be that the Respondent should make a disclosure to any new employer of the fact of her appearances before this Committee in January 2018 and in July 2018 and of the decisions of the Committee in relation to both such hearings. The final requirement of the Committee in this respect is that the respondent should not accept a 'sole charge position' at any time during her employment during this next period of postponement of sanction."
The Committee directed that the hearing be postponed for a further 12 months.
Andy (pictured right) will be joined at the The Moores Orthopaedic Clinic by fellow surgical specialist Chris Jordan, and Managing Director Richard Hoile.
The clinic is situated just off the M3, thirty minutes from the M25.
It is equipped with a CT scanner, mobile digital radiography and two surgical theatres with a full complement of orthopaedic kit including for total hip replacement in cats and all sizes of dogs.
To ensure best patient outcomes the surgical suite has its own HEPA-filtered ventilation system, isolated from the rest of the clinic, which Andy says exceeds guidelines for human orthopaedic theatres and will reduce the risk of infection.
Andy said: “The Moores Orthopaedic Clinic fills a gap in the market to provide high-class specialist orthopaedic care at a reasonable price.
"We have two very experienced specialist surgeons and a clinic designed from the ground-up to reduce the risk of complications after surgery.
"We will be able to provide the very best orthopaedic care and the best possible outcomes after surgery.
"And without the high overheads many referral centres often face, we will be able to achieve this at a very competitive price.
"I can’t wait to start seeing cases in May.”
Non-urgent cases can be booked from April 2023 using the online referral form: https://mooresortho.com/contact/
In the lead up to opening in May, Andy is available for remote consultations, client visits, to consult/operate on select cases in your own clinic or to discuss cases via email andy@mooresortho.com
mooresortho.com
Eleven members of staff at the Royal College of Veterinary Surgeons are growing moustaches this month in support of the Movember Challenge, a campaign which raises funds to help combat prostate cancer.
Simon Wiklund, Advisory Manager and instigator of the College's participation in Movember 2010, said: "Visitors to the College over the next few weeks shouldn't be alarmed if some members of staff begin to resemble a Village People tribute band. I suggested this to the chaps last week, and was delighted so many were willing to look daft for such a good cause."
According to the Movember website, the aim is simple: "One man dies from prostate cancer every day in the UK. Movember challenges men to change their appearance and the face of men's health by growing a moustache. All MoBros should be clean shaven on 1 Movember and then grow a moustache for the entire month. The moustache becomes the ribbon for men's health, the means by which awareness and funds are raised for cancers that affect men."
The RCVS team - 'All 'Taches Great and Small' - comprises at least one member of every department in the College, so whilst the team as a whole will be raising as much money as it can, the College says it expects interdepartmental competition to get "quite hairy".
"In spite of ourselves, reputations are at stake here," admits Simon. "We're a mixed-ability team, so it will be interesting to see who sports the best tache at the end of Movember. This is no trivial hirsute."
Lending his support to the team's efforts, and off to something of a head start in the facial forestry department, is RCVS President Peter Jinman. He said: "I'm impressed that so many of the gents on the staff have taken it upon themselves to support The Prostate Cancer Charity in this way. If it's true that eight out ten chaps really do prefer whiskers, they should raise a decent amount of money."
Anyone wishing to support the All Taches Great & Small team in their bristling endeavours should please visit their fundraising pages (via www.rcvs.org.uk/movember). Donations can be made to individual MoBros, or to the team as a whole.
The letter called on the UK government to ensure there is a duty on the state to have due regard for animal welfare in the development and implementation of policy, as Article 13 of the Lisbon Treaty sets out. Under the UK’s Animal Welfare Acts, accountability for the treatment of an animal focuses on the animal keeper, but not on the state.
The coordinated letter from the veterinary professions follows widespread media attention after a House of Commons debate, wherein MPs voted down an amendment tabled by Green MP Caroline Lucas to include the principles set out in Article 13, which also states animals are sentient, in the EU (Withdrawal) Bill. Since Article 13 has its origins in a treaty rather than a regulation, it did not qualify to automatically transfer into UK law as part of the EU (Withdrawal) Bill.
The signatories of the Daily Telegraph letter span all areas of veterinary work including small and large animal practice, research, government and academia as well as including former UK Deputy Chief Veterinary Officers, Officers of BVA specialist divisions and the Chief Veterinary Officer of SSPCA, amongst others.
BVA Senior Vice President Gudrun Ravetz has been leading BVA’s lobbying on this issue while BVA President John Fishwick recovers from a back operation. Gudrun said: "The public and professional response to the Article 13 vote was astonishing, but there was much misunderstanding borne from sensationalist headlines that suggested the MPs who voted the amendment down do not believe in animal sentience. The real crux of the debate got lost in this noise.
"BVA supports the principle of Article 13, since it not only recognises that animals are sentient, but importantly puts a duty on the state to have due regard for animal welfare in the development and implementation of policy."
The company says the new range performs as well as the leading brands and delivers consistently reliable sterilisation, but at a much lower price point than the market has seen before. The entry level 8 Litre machine retails at £1,100.
The Yeson machines range in size from an 8 litre to a 22 litre capacity and offer quiet Class B operation, 7 pre-set sterilisation programs, B&D Helix testing and a choice of printer or USB reporting.
Yeson UK MD Will Thomas said: "The autoclave market has been dominated by a few major players for many years and until now they’ve been largely unchallenged. Many people are now asking “why should I pay thousands more for a utility machine such as an autoclave? We’re just hoping that we can meet the demand."
For more information, visit www.yeson-uk.com
The two-month campaign is comprised of a series of very polished videos which are now being shared on YouTube.
The videos share the experiences of a number of veterinary professionals from PSS practices who talk to the camera first as owners themselves, and then as vets.
The College says the aim is to demonstrate to the public that their animals will receive veterinary care from empathetic practice teams committed to delivering the kind of veterinary care they would want for their own animals.
Mandisa Greene, Chair of the Practice Standards Group, said: "In order for a veterinary practice to be accredited under the Practice Standards Scheme it needs to demonstrate that it is meeting a broad range of stringent standards and undergo a rigorous independent assessment every four years.
"However, we know that awareness and understanding of the Scheme amongst animal owners is relatively low, and that there is always more we can do to help change this. We have therefore developed this digital campaign to help RCVS-accredited practices explain to animal owners what RCVS-accreditation means, and why they should care about it.
"We think it’s important that RCVS-accredited practices, which go through a great deal of effort and work to achieve their accreditation, receive the recognition they deserve and we hope that they will help us to spread the word far and wide."
Ian Holloway, RCVS Director of Communications, said: “A vital ingredient of this campaign will be the support and involvement of RCVS-accredited practice teams right across the country. Throughout the two-month campaign, we will be posting lots of wonderful video stories, pictures and PSS infographics across all of our social media channels, along with other fun ways to help spread the word.
"We’re posting launch packs to all accredited-practice premises this week, which include a variety of campaign posters to display in waiting rooms and details of how to download all the digital resources from our campaign website for use in practice and online.
"We really hope that everyone associated with an RCVS-accredited practice, including their clients, will be able to share this campaign across their own channels as widely as possible, remembering to use the campaign hashtag #YourKindOfVets, of course!"
Anyone wanting more information about the campaign should email: yourkindofvets@rcvs.org.uk.
Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for I/V administration.
It is also licensed for I/M administration in cattle; it has zero milk withdrawal and short one day meat withdrawal and sedation occurs in cattle within two minutes I/V and five to 10 minutes I/M.
Sedaxylan 20 mg/ml joins Dechra’s Nerfasin vet 100 mg/ml solution in the company’s anaesthesia and sedation range. Nerfasin vet also contains xylazine and is licensed for I/V administration for sedation and premedication prior to general anaesthesia in horses and cattle.
Alana McGlade, national sales manager at Dechra, said: “Dechra offers a comprehensive range of anaesthesia and sedation products allowing vets to customise protocols to the individual animal.
"Sedaxylan 20mg/ml and Nerfasin vet 100 mg/ml solution provide vets with flexible and convenient dosing options.”
Both Sedaxylan 20 mg/ml and Nerfasin vet 100 mg/ml are available in 25ml vials.
For more information, talk to your Dechra territory sales manager.
www.dechra.co.uk.
The Pig Veterinary Society's revised 2009 edition of Casualty Pig, funded by the BVA Animal Welfare Foundation (BVA AWF) is now available.
This booklet is intended for the use of stock keepers on farms, staff in abattoirs, veterinary surgeons, and by transporters, to give guidance and knowledge in care, treatment, and euthanasia of the casualty pig. It also indicates the responsibilities and decisions related to the "Casualty Pig", as well as the legal requirements.
Speaking on behalf of the charity, BVA AWF Chairman and veterinary surgeon, Carl Padgett, said "This updated version has more emphasis on the care of and welfare of the casualty pig than earlier editions. This is a useful and easy to use guide that gives details of 'decision options' with a series of examples related to care, treatment and euthanasia."
Individuals can obtain copies of The Casualty Pig by contacting BVA AWF trustee David Chennells, via email at acornhousevets@btconnect.com.
This, say the authors, should in turn help them to communicate potential performance problems more effectively with their clients.
Conducted by Dr Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust in Newmarket, the study compared the real-time application of the Ridden-Horse-Ethogram with analysis of video recordings of the horses by a trained assessor and determined whether vets, after preliminary training, could apply the ethogram in real time in a consistent way and in agreement with an experienced assessor.
Twenty horse and rider combinations were used for the study. The horses were in regular work and were capable of working ‘on the bit’. They were assessed by a chartered physiotherapist and then a Society of Master Saddlers (SMS) qualified saddle fitter checked the fit, placement, balance and suitability of each horse’s saddle. Eleven horses were found to have ill-fitting saddles and 14 had back muscle tension or pain but these did not influence the behaviour scores.
The horses were also assessed by an independent lameness expert. Sixteen showed low-grade lameness or abnormalities of canter, which were likely to be pain induced but did not prevent the horses from being used for the study.
All 20 horses were given a 15-minute ridden warm-up before executing an 8-minute purpose-designed preliminary level dressage test. During each dressage test a team of 10 equine vets, who were selected from 40 volunteers and given preliminary training, applied the Ridden-Horse-Ethogram. They assessed each horse for the presence of a total of 24 behaviours that occur more commonly in lame horses compared with non-lame horses. It has previously been shown that the presence of ≥8 behavioural markers is likely to indicate the presence of musculoskeletal pain.
All behaviours were scored with a binary method as present or absent. The ethogram was also applied to each horse by an experienced trained assessor (Dr Dyson) and the tests were filmed so that the experienced assessor could make a comparison between her real-time behaviour assessments and video analysis.
There was good agreement between the expert’s scores and the volunteer vets’ scores and excellent consistency in overall agreement among the volunteers. The scores also reflected the volunteers’ capacity to use the ethogram to identify lameness status, with higher scores awarded to the lame horses compared with the non-lame horses.
There was no significant difference in real-time scores and video-based scores for the experienced assessor, verifying the reliability of the system.
Sue said: "The study confirms that with basic training veterinary observers can use the ridden horse ethogram with consistency as an effective tool to help identify musculoskeletal pain which could reflect lameness or back or sacroiliac pain.
"The volunteers were unanimously positive about the potential value of the ethogram in helping them to determine the presence of musculoskeletal pain in horses performing poorly or at pre-purchase examinations."
Sue and her team are now working with the evidence-based online educational resource Equitopia, in conjunction with Padma Videos, to produce a training video to enable vets, owners, riders, trainers and paraprofessionals to learn how to apply the Ridden-Horse-Ethogram.
For more information, email info@equitopiacenter.com.
For the study, researchers from the RVC’s VetCompass Programme identified 2,105 hypothyroidism cases diagnosed amongst a study population of 905,553 UK dogs.
This revealed an annual frequency of one case in 400 dogs (0.23%) for the condition, with the most common breeds diagnosed being Standard Doberman Pinschers (x 17.02), Tibetan Terriers (x11.25), Boxers (x10.44) and Alaskan Malamutes (x 9.71).
The average age at first diagnosis was 7.65 years.
Other findings included:
Dr Rebecca Geddes, Lecturer in Small Animal Internal Medicine at the RVC Queen Mother Hospital for Animals and last author of the paper, said: “It is great to have this data from UK primary care practices, which will help highlight high risk breeds to veterinary surgeons so they can diagnose and treat affected dogs as early as possible. Hypothyroidism is usually straightforward to manage with medication that can greatly improve quality of life in affected dogs.”
Matt has taken over as hospital director from David Walker, who has now moved to the role of referrals managing director in the south of the UK for Linnaeus.
Matt said: “I certainly have some big shoes to fill but working as clinical director alongside David was a great grounding and we work well together.
“Essentially, I was his running mate back then but now I am stepping up to take on the main role, with all the additional responsibilities it entails, and I’m determined to make it my own.
“I know I have the drive, the desire, the clarity of purpose and the dedication to succeed.
"I also know what an incredible operation I have inherited from David.
“One of the key things about Anderson Moores is that every member of the team works together in the same location to support every aspect of a pet’s treatment and recovery, so whatever service they may need is all available under the same roof.”
www.andersonmoores.com/homewww.zeropainphilosophy.com
IVC is one of 115 companies certified in the UK, including Vodafone, Bentley, Amazon and Pfizer, and the first veterinary organisation.
The certification benchmarks organisations globally on their people practices, including strategy, work environment, talent acquisition, learning, diversity, equity & inclusion, and wellbeing.
IVC says the certification reflects a series of initiatives introduced to enhance the colleague experience, including private healthcare options for all staff, a family-friendly policy, a growing network of wellbeing champions and mental health first aiders, and the launch of two new training centres.
Duncan Phillips, IVC Evidensia CEO UK & Ireland, said: “This certification is a welcome acknowledgement of the progress we’ve made, and a motivator to keep improving the experience for every colleague across the UK.”
Androna Benade, Regional Manager for UK and Ireland, Top Employers Institute said: “With veterinary professionals playing a vital role in animal health, food safety, and public wellbeing, this recognition sends a powerful message about the importance of valuing and investing in the people behind the profession.
"As the UK faces ongoing workforce challenges in the veterinary sector, IVC Evidensia’s achievement sets a benchmark for how the profession can be supported, retained, and celebrated as a critical part of the UK economy and society.”
www.top-employers.com
Elanco Companion Animal Health has launched of Dexdomitor 0.1 mg/ml, adding to its range of alpha-2 agonists and antagonists.
Produced and manufactured in partnership with Orion Corporation, Elanco says Dexdomitor 0.1 mg/ml contains all the properties of dexmedetomidine in a formulation that allows accurate and convenient dosing for the smallest patients. It can be used as a sedative for non-invasive, mild to moderately painful procedures and examinations which require restraint, sedation and analgesia in dogs and cats. It can also be used for deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures and as a pre-medication in dogs and cats before induction and maintenance of general anaesthesia.
Dexdomitor 0.1 mg/ml has been designed to provide accurate dosing in very small dogs (up to 5kg) for sedation and pre-medication, small to mid-size dogs (up to 20kg) for pre-medication, and small cats (up to 3kg) for sedation and pre-medication.
Ed Whittle MRCVS, technical consultant at Elanco Companion Animal Health said: "With nearly a quarter of dogs weighing less than 6kg and nearly three-quarters weighing less than 23.1kg1, Dexdomitor 0.1mg/ml is ideal for small animals that require low concentration doses of dexmedetomidine for convenient and accurate dosing".
Elanco has has also produced a sedation and pre-medication dosing guide to educate veterinary professionals on the recommended doses for its range of alpha-2 agonists and alpha-2 antagonists.
For further information contact your Elanco Companion Animal Health key account manager or email elancoCAH.uk@elanco.com.
Specifically, Ms Hodgkinson was alleged to have placed five orders between 1 September 2013 and 1 April 2015:
The medications for charges (i) to (iii) above, were intended for her own personal use, as she had previously at various times been prescribed Codeine, Naproxen and Amitriptyline after being involved in a serious car accident in November 2012, as a result of which she suffered from chronic back pain and other problems.
Charges (iv) and (v) above, were intended for her dog, ‘Minnie’, but the dosages ordered were incorrect. The medications were never removed from the practice or given to Minnie, but were instead returned to the wholesaler.
From the outset Ms Hodgkinson admitted the charges against her, although she believed that other staff at the practice had placed similar personal orders and that she had been given permission to do so as well. Ms Hodgkinson also accepted that the facts amounted to disgraceful conduct in a professional respect.
The Committee accepted Ms Hodgkinson’s admission of the charges and, accordingly, found the charges proved. The question of whether the facts amounted to serious professional misconduct was, however, a matter for the Committee’s judgement, notwithstanding Ms Hodgkinson’s admission.
In reaching its decision, the Committee took into account Ms Hodgkinson’s assertion that she believed she had been given permission to order medication through the practice. She did admit however that she must have been mistaken in that belief. The Committee also took note of the College’s submission that a number of aggravating features were present which amounted to serious professional misconduct, namely: the potential risk posed to animal welfare; Ms Hodgkinson’s ignorance of fundamental legislative provisions; a breach of trust placed in her by virtue of her RVN status; the fact that the misconduct was repeated over a period of time; and a lack of awareness of professional responsibilities at the time of the conduct. The Committee therefore had no hesitation that the conduct did amount to serious professional misconduct.
The Committee then turned to the question of sanction. A number of mitigating factors were put forward in Ms Hodgkinson’s defence including the fact that a period of lengthy suspension or removal from the register would result in her losing an offer of employment, the fact that up to the relevant conduct she had had an unblemished career and the fact that she had made early admissions of guilt and shown insight into her misconduct.
The Committee decided that a period of 10 months’ suspension would be appropriate and proportionate in this case.
Chitra Karve, who chaired the Committee and spoke on its behalf, said: "The length of the period of suspension…is intended to reflect this Committee’s view, assisted as it has been by the experience and knowledge of a practising RVN and a veterinary surgeon, of the seriousness of the respondent’s conduct in its totality and of the need for the message to go out to all veterinary professionals that the ordering of POMs without the authority of a valid prescription is a most serious instance of misconduct. In such circumstances the personal mitigations that a practitioner might place before a Disciplinary Committee, whilst not immaterial, is inevitably of limited persuasion. And that is what this Committee has concluded in this particular case, having reflected carefully on the mitigation factors placed before it.
"Having weighed the matters of personal mitigation against the fact that a rudimentary knowledge of the governing legislation was effectively all that was required of the Respondent to ensure that the misconduct complained of did not occur, it is the clear view of the Committee that it would be failing in its public duty were it to do anything less than to impose a period of suspension from practice and the least period of suspension that is appropriate in this case is one of ten months. The Committee therefore instructs the Registrar to act accordingly."
Stronghold Plus contains the same selamectin found in common-or-garden Stronghold, licensed for the treatment of fleas, flea allergic dermatitis, ear mites (Otodectes cynotis), roundworm (Toxocara cati), intestinal hookworms (Ancylostoma tubaeforme), biting lice (Felicola subrostratus), and for the treatment of heartworm disease caused by Dirofilaria immitis.
To that has been added sarolaner, a new acaricide and insecticide which is also effective for five weeks against Ixodes ricinus, Ixodes hexagonus, and for four weeks against Dermacentor reticulatus and Rhipicephalus sanguineus.
Clint Lewis, Executive Vice President and President International Operations, said: "The launch of Stronghold Plus enables Zoetis to offer veterinarians in the European Union a new topical choice that treats the parasites commonly presenting a threat to cats with one convenient monthly dose.
For the first time, we have combined our new, versatile parasiticide sarolaner with the active ingredient in Stronghold, selamectin, resulting in the first approval of sarolaner for use in cats. We see sarolaner as a promising platform for future product lines and lifecycle innovations and are pleased with the positive data that sarolaner and its combination continue to generate in studies.”
Domenico Otranto, Professor of Parasitology at Bari University in Italy, who has reviewed the product data of Stronghold Plus, said: "A number of laboratory and field studies show the efficacy of the single spot-on application of Stronghold Plus for at least one month. Veterinarians in Europe now have a very effective option for the treatment and control of four prominent species of ticks commonly found on cats while maintaining proven efficacy against fleas, GI worms, heartworms, ear mites and lice. Ultimately, pet owners and practitioners have a new tool for improving health and welfare of cats."